Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001172661-26-005106

Stakes reported in this filing

Reporting person Shares Of the class
Polar Capital Holdings Plc 5,022,084 5.19%
Polar Capital LLP 5,022,084 5.19%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…